Clinical Trials Directory

Trials / Completed

CompletedNCT04824781

Recovery From Paranoia: a Qualitative Exploration

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers

Summary

Paranoia, the experience of undue or excessive mistrust, exists on a continuum which includes suspicious thoughts, ideas of reference, and persecutory delusions. Persecutory delusions refers to strong unfounded fears that others intend harm. These fears are very common. They affect around 70% of patients with schizophrenia. They can be distressing and make day-to-day tasks difficult. However, current treatments are limited and a significant proportion of people do not benefit sufficiently. Therefore, improvements in treatment are needed. A better understanding of the experience of recovery from paranoia will help inform theoretical understanding and treatment development. Currently we do not fully understand what causes paranoia to occur, persist, or end. As such, it is critical to understand the experiences of those who have recovered, in particular what elements encourage recovery. Therefore, the aim of this study is to gain a first-person perspective on how people recover from paranoia and what psychological processes are important for recovery from paranoia. Using a qualitative approach appropriate for exploratory research, semi-structured interviews will be conducted with 12-15 patients who have recovered from paranoia. Interviews will be analysed using interpretative phenomenological analysis, a qualitative research approach which aims to provide insight on how an individual, in a particular situation, makes sense of their experience.

Conditions

Interventions

TypeNameDescription
OTHERQualitative interviewParticipants will be interviewed about their experiences of recovery from paranoia.

Timeline

Start date
2021-06-09
Primary completion
2021-07-27
Completion
2022-02-16
First posted
2021-04-01
Last updated
2022-05-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04824781. Inclusion in this directory is not an endorsement.